- PR Newswire•12 days agoRXi Pharmaceuticals Corporation Discusses Competitive Advantage, Goals and Milestones for 2016-2017 in New SNNLive Newscast on StockNewsNow.com
LOS ANGELES, Nov. 28, 2016 /PRNewswire/ -- StockNewsNow.com , The Official MicroCap News Source™, today published an SNNLive Newscast with Pamela Pavco, Ph.D., Chief Development Officer for RXi Pharmaceuticals ...
- TheStreet.com•23 days ago
These under-$10 stocks are within range of triggering breakout trades. Here's how to trade them from here.
- Marketwired•25 days agoThe Life Sciences Report Examines the Agreement That Is Launching RXi Pharmaceuticals into Dynamic Immuno-Oncology Arena
By securing an exclusive option to acquire MirImmune Inc., RXi Pharmaceuticals Corp. has expanded its reach into the "high-value" field of immune-oncology, a move that has energized the company ...
RXII : Summary for RXi Pharmaceuticals Corporation - Yahoo Finance
RXi Pharmaceuticals Corporation (RXII)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
|Bid||1.00 x 1000|
|Ask||2.10 x 200|
|Day's Range||1.65 - 1.88|
|52 Week Range||0.94 - 4.24|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-1.25|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|